STAT3 and central nervous system cancer: We found that ciglitazone had multiple actions on the glioma, including the inhibition of angiogenesis, migration, decreased STAT3 phosphorylation, arrest of the cell cycle, activation of proteasome and lysosome, and increased autophagy.